SCP
BLU

Sender Company & Partners’s BELLUS Health Inc. BLU Stock Holding History

Sender Company & Partners’s Portfolio BLU Stock Details BLU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-108,719
Closed -$875K – 117
2021
Q4 		$875K Buy
+108,719
New +$721K 0.45% 61

Other funds holding BLU

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
PCOC
Power Corp of Canada Montreal, Quebec, Canada $745M AUM 22.7% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Sender Company & Partners's BLU Position: Q1 2022 in Review

Sender Company & Partners sold out of BELLUS Health Inc. (BLU) in Q1 2022, closing a stake of 108,719 shares — an estimated $875K sold.

Sender Company & Partners first reported a position in BLU in Q4 2021 and held it in 1 quarter. The position peaked at $875K in Q4 2021. 77 funds tracked by Wall St. Rank hold BLU as of Q1 2022.

  • Sender Company & Partners reported no remaining BELLUS Health Inc. position as of Q1 2022 after selling out during the quarter.
  • Sender Company & Partners sold 108,719 BELLUS Health Inc. shares in Q1 2022, an estimated $875K.
  • Sender Company & Partners first reported a position in BELLUS Health Inc. in Q4 2021 and held it in 1 quarter.
  • Sender Company & Partners's BELLUS Health Inc. position peaked at $875K in Q4 2021.
  • 77 funds tracked by Wall St. Rank held BELLUS Health Inc. as of Q1 2022.

Based on Sender Company & Partners's 13F filing for Q1 2022, filed 17 May 2022.